Novavax, Inc. (NVAX)
8.56
-0.11
(-1.27%)
USD |
NASDAQ |
Jun 10, 16:00
8.59
+0.03
(+0.35%)
Pre-Market: 08:37
Novavax 1 Year Total Returns (Daily) : 18.89% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 18.89% |
| June 09, 2026 | 17.00% |
| June 08, 2026 | 15.70% |
| June 05, 2026 | 35.77% |
| June 04, 2026 | 42.52% |
| June 03, 2026 | 40.50% |
| June 02, 2026 | 44.41% |
| June 01, 2026 | 43.19% |
| May 29, 2026 | 52.57% |
| May 28, 2026 | 49.13% |
| May 27, 2026 | 50.27% |
| May 26, 2026 | 44.28% |
| May 22, 2026 | 26.34% |
| May 21, 2026 | 26.30% |
| May 20, 2026 | 20.70% |
| May 19, 2026 | 14.99% |
| May 18, 2026 | 32.69% |
| May 15, 2026 | 44.04% |
| May 14, 2026 | 56.88% |
| May 13, 2026 | 49.11% |
| May 12, 2026 | 51.74% |
| May 11, 2026 | 59.00% |
| May 08, 2026 | 51.80% |
| May 07, 2026 | 55.13% |
| May 06, 2026 | 54.20% |
| Date | Value |
|---|---|
| May 05, 2026 | 29.19% |
| May 04, 2026 | 25.27% |
| May 01, 2026 | 25.43% |
| April 30, 2026 | 18.82% |
| April 29, 2026 | 24.14% |
| April 28, 2026 | 18.12% |
| April 27, 2026 | 20.99% |
| April 24, 2026 | 16.27% |
| April 23, 2026 | 9.10% |
| April 22, 2026 | 35.20% |
| April 21, 2026 | 41.26% |
| April 20, 2026 | 44.50% |
| April 17, 2026 | 47.33% |
| April 16, 2026 | 39.35% |
| April 15, 2026 | 35.99% |
| April 14, 2026 | 30.89% |
| April 13, 2026 | 38.40% |
| April 10, 2026 | 49.54% |
| April 09, 2026 | 26.52% |
| April 08, 2026 | 33.44% |
| April 07, 2026 | 22.02% |
| April 06, 2026 | 27.72% |
| April 02, 2026 | 28.76% |
| April 01, 2026 | 33.67% |
| March 31, 2026 | 26.99% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Merck & Co., Inc. | 51.71% |
| Pfizer Inc. | 12.75% |
| AbbVie, Inc. | 22.60% |
| Amgen, Inc. | 18.55% |
| Fate Therapeutics, Inc. | 11.98% |